IDT.jpg

Integrated DNA Technologies Announces Translational CRISPR Portfolio Expansion with Product Innovation Updates

Friday, July 18, 2025
New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies
IDT.jpg

IDT: The Original Innovator in Gene Fragments, Leadership through Science and Quality

Monday, July 14, 2025
IDT launches all-inclusive gene fragments from 7 cents per base with 25% lower turnaround times and next-day shipping powered by its cutting-edge synthetic biology facility
IDT.jpg

Integrated DNA Technologies Announces Innovation Roadmap Advances to Infectious Disease Portfolio

Wednesday, June 18, 2025
Expanded portfolio offerings include first-to-market product launches to support global health challenges New infectious disease research solutions to be spotlighted at ASM Microbe 2025
Perspective Therapeutics.jpg

Perspective Therapeutics Brings Energy to the Radiopharma World

Monday, June 9, 2025
The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.
Pani Clean.jpeg

Pani Clean Installs Off-Grid Nitrate-to-Ammonia Pilot Unit at the Iowa Wastewater and Waste to Energy Research Program (IWWERP) Tech Park

Monday, June 9, 2025
A solar-powered nitrate treatment unit is installed to demonstrate circular resource recovery
IDT.jpg

Integrated DNA Technologies Installs Custom Solutions Program to Accelerate Innovation in Synthetic Biology

Thursday, June 5, 2025
White glove manufacturing service aims to enhance design-build-test cycle and drive rapid innovation
IDT.jpg

Integrated DNA Technologies, Aldevron pioneer first personalized CRISPR therapy powered by mRNA

Tuesday, May 20, 2025
Aldevron and Integrated DNA Technologies – both part of the Danaher Corporation – have achieved a medical milestone with the successful manufacture of the world’s first personalized CRISPR gene-editing drug product to treat an infant suffering from a rare and life-threatening genetic condition known as urea cycle disorder (UCD).
Steve Davis received Toast to Business Award

Greater Iowa City, Inc. celebrates Johnson County businesses at inaugural ‘A Toast to Business’ Awards ceremony

Monday, May 5, 2025
Steven Davis, Co-Founder and CEO of Bio::Neos, Inc. —a BioVentures Center tenant—received the Youth Engagement Award.